New Delhi: The Supreme Court on Monday issued notice to the central government on a plea seeking investigation into illegal and unethical clinical trials of drugs which are yet to be approved by the drug controller. An apex court bench headed by Justice RM Lodha issued notice on a plea by Madhya Pradesh-based 'Swasthya Adhikar Manch' that, in a large number of cases, multinational corporations were using contract research organisations...
03:11 PM, Feb 06, 2012
![]()
It's a eureka moment for scientists ... Experts have made a breakthrough with a malaria Vaccine being clinically tested in Africa right now. The new ...
11:57 AM, Oct 24, 2011
New York: Despite reports of liver damage in some women using black cohosh to ease menopause symptoms, clinical trials testing one major brand of this herb have so far found no evidence that it is to blame, according to a research review. Extracts of black cohosh, a plant native to North America, are marketed as a "natural" form of hormone replacement therapy (HRT) and are most commonly used to treat...
02:49 PM, Jan 29, 2011
Hyderabad: Bharat Biotech, a city based biotechnology firm, on Monday announced the launch of India's first indigenously developed cell culture H1N1 Swine Flu Vaccine under the brand name HNVAC. HNVAC is the vaccine manufactured in cell culture, a highly sterile and controlled manufacturing process instead of eggs, the company said in a release. The vaccine was tested extensively in one of the largest Phase I, II and III clinical trials...
03:25 PM, Oct 18, 2010
New Delhi: For the first time ever, US researchers will be using human embryonic stem cells for treatment of spinal cord injuries. The stems cells were tested successfully in rats enabling them to once again walk and run. This is the first phase of clinical trials which will determine the safety of stem cell treatment. It will enroll up to 10 patients who have suffered spinal cord injuries, injecting them...
07:46 PM, Oct 12, 2010
It is learnt that Bhopal Memorial Hospital and Research Centre had been carrying out drug trials on 151 victims. ...
08:40 AM, Jun 17, 2010
China says its single shot vaccine shows no severe adverse effects. ...
03:15 PM, Aug 23, 2009
University researchers are testing hundreds of local volunteers. ...
12:23 AM, Aug 13, 2009
A RTI filed in August said 49 babies died during trials. ...
12:32 AM, Sep 08, 2008
Most of these babies had not even celebrated their first birthday. ...
08:30 AM, Aug 18, 2008
displayed with permission. Use of the CNN name and/or logo on or as part of CNN-IBN does not derogate from the intellectual property rights of Cable News Network in respect of them.
Disclaimer: Network18 Media & Investments Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
Disclaimer: TV18 Broadcast Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
